Adverum Biotech
Caroline L. is a seasoned Quality Assurance professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as QA Specialist III CMC at Adverum Biotechnologies since May 2024, Caroline previously held QA Specialist III positions at List Biological Laboratories and Quality Assurance Specialist roles at Adverum Biotechnologies, CSBio, and Precision For Medicine, where responsibilities included administering Quality Systems, performing gap assessments, and managing ISO/GxP quality systems. Earlier experience includes a Senior R&D Specialist position at Boston Scientific Corporation and a Research Assistant role at Full Moon BioSystems. Caroline holds a Bachelor of Science degree in Biology from UC Irvine.
Adverum Biotech
9 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.